GB830857A - Aminoalkyl aryl ethers - Google Patents

Aminoalkyl aryl ethers

Info

Publication number
GB830857A
GB830857A GB3011/58A GB301158A GB830857A GB 830857 A GB830857 A GB 830857A GB 3011/58 A GB3011/58 A GB 3011/58A GB 301158 A GB301158 A GB 301158A GB 830857 A GB830857 A GB 830857A
Authority
GB
United Kingdom
Prior art keywords
methyl
benzoate
ethyl
compounds
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3011/58A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of GB830857A publication Critical patent/GB830857A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises compounds of the formula <FORM:0830857/IV (b)/1> (wherein R is methyl or ethyl, R1 is methylene, ethylene or propylene, R11 is methyl or ethyl and R111 is hydrogen, methyl or ethyl, or R11 and R111 may, together with the vicinal nitrogen atom, form a saturated heterocyclic ring) and acid-addition salts thereof; and their preparation by reacting an alkyl 2-hydroxy-3-methyl-benzoate with a reactive ester of an appropriate tertiary amino alcohol. Suitable reactive esters are halides or alkyl- or aryl-sulphonic esters and the reaction is advantageously carried out in a solvent in the presence of an acid acceptor such as an alkali metal hydroxide, alcoholate or carbonate. The compounds may also be prepared by reacting the benzoate with, for example, a phthalimidoalkyl halide, a halocarboxamide or a nitrile of a halocarboxylic acid and then converting the phthalimido, carboxamide or nitrile group into an amino group and alkylating this. Amino-propyl ethers may also be prepared by reacting the benzoate with the corresponding acrylic acid derivatives. A further method for the preparation of the compounds of the invention comprises the splitting off of carbon dioxide from the corresponding carbonates. Examples describe the preparation of compounds wherein R in the above general formula is variously methyl and ethyl, R1 is variously ethylene, trimethylene and propylene and -NR11R111 is variously dimethylamino, diethylamino, piperidino and morpholino, hydrochlorides and phosphates of some of the products also being described. In further examples, methyl 2-hydroxy-3-methyl benzoate sodium salt and p-toluene sulphonic acid b -chloroethyl ester give methyl-2-(b -dimethylamino-ethoxy)-3-methyl-benzoate and this with dimethylamine gives methyl 2-(b -dimethylamino-ethoxy)-3-methyl-benzoate, which is also prepared by the action of dimethylamine on methyl 2-(b -bromo-ethoxy)-3-methyl-benzoate, itself prepared from the sodium salt of methyl 2-hydroxy-3-methyl-benzoate and ethylene dibromide. Specification 822,931 is referred to.ALSO:Veterinary and pharmaceutical anaesthetic compositions comprise one or more compounds of the formula <FORM:0830857/VI/1> (wherein R is methyl or ethyl, R1 is methylene, ethylene or propylene, R11 is methyl or ethyl and R111 is hydrogen, methyl or ethyl, or R11 and R111 may, together with the vicinal nitrogen atom, form a saturated heterocyclic ring) or acid-addition salts thereof in admixture with a pharmaceutical carrier or carriers. Specification 822,931 is referred to.
GB3011/58A 1957-02-21 1958-01-29 Aminoalkyl aryl ethers Expired GB830857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF22404A DE1118219B (en) 1957-02-21 1957-02-21 Process for the preparation of basic substituted alkyl ethers of o-cresotinic acid esters and their salts

Publications (1)

Publication Number Publication Date
GB830857A true GB830857A (en) 1960-03-23

Family

ID=7090428

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3011/58A Expired GB830857A (en) 1957-02-21 1958-01-29 Aminoalkyl aryl ethers

Country Status (6)

Country Link
AT (1) AT203001B (en)
DE (1) DE1118219B (en)
DK (2) DK89717C (en)
FR (1) FR1241124A (en)
GB (1) GB830857A (en)
NL (1) NL225119A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1288066A (en) * 1968-09-16 1972-09-06
FR2192811B1 (en) * 1972-07-20 1975-08-08 Centre Etd Ind Pharma
FR2215217A1 (en) * 1973-01-23 1974-08-23 Centre Etd Ind Pharma Ortho thymotic acid di alkyl amines - coronary dilators, anti arrhythmic agents, local anaesthetics and antitussives
IT1051445B (en) * 1975-07-16 1981-04-21 Recordati Chem Pharm THERAPEUTICALLY ACTIVE BENZOIC ACID DERIVATIVES AND PROCEDURE TO PREPARE THEM

Also Published As

Publication number Publication date
NL225119A (en) 1962-10-15
DK93084C (en) 1962-03-26
AT203001B (en) 1959-04-25
DE1118219B (en) 1961-11-30
DK89717C (en) 1960-09-19
FR1241124A (en) 1960-09-16

Similar Documents

Publication Publication Date Title
GB1513950A (en) Benzomorphane derivatives
GB830857A (en) Aminoalkyl aryl ethers
GB1078251A (en) Benzimidazolone derivatives
GB776717A (en) Derivatives of mandelic acid and their salts and process for the preparation thereof
GB858792A (en) New pyridazine derivatives and processes for their manufacture
ES384946A1 (en) Novel adamantylurea derivatives and a process for the preparation thereof
GB856587A (en) Substituted piperidines
ES350523A1 (en) Aryloxyisoalkyl-Delta&lt;2&gt;-Imidazolines
DE2964850D1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
GB889223A (en) Phenylpiperazinylalkyl esters and amides
US3239526A (en) 3-phenyl-4-aminocinnolines
GB1089215A (en) New penicillins and process for preparing them
GB753742A (en) Erythromycin acid esters
GB833474A (en) Piperazine derivatives
GB1073770A (en) Pyridazone derivatives and process for their preparation
SU527134A3 (en) Method for preparing benzylamine derivatives or their salts
US2460224A (en) Biotin intermediate
GB1184395A (en) Substituted Piperazine Derivatives
GB931788A (en) Improvements in or relating to benzhydryl esters
GB803149A (en) Improvements in or relating to the preparation of thyroxine analogues
GB869474A (en) Dialkylamides of alpha-substituted fatty acids
GB781528A (en) Substituted ethylene dipiperazines
GB1000803A (en) New uracil derivatives and process for their production
IL40169A (en) Aminoalcohol esters and salts thereof,their preparation and pharmaceutical compositions containing them
GB990627A (en) Method of preparing non-migratory colour couplers for yellow